Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/42993| metadata.artigo.dc.title: | Coronavirus disease 2019 (COVID-19): immunological approaches and emerging pharmacologic treatments |
| metadata.artigo.dc.creator: | Goodarzi, Pedram Mahdavi, Farzad Mirzaei, Rasoul Hasanvand, Hamze Sholeh, Mohammad Zamani, Farhad Sohrabi, Masodreza Tabibzadeh, Alireza |
| metadata.artigo.dc.subject: | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Drug targets Antiviral strategies Immunological approaches |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | Nov-2020 |
| metadata.artigo.dc.identifier.citation: | GOODARZI, P. et al. Coronavirus disease 2019 (COVID-19): immunological approaches and emerging pharmacologic treatments. International Immunopharmacology, [S.l.], v. 88, Nov. 2020. |
| metadata.artigo.dc.description.abstract: | The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to develop antiviral strategies for the treatment of COVID-19 are underway. The rapidly increasing understanding of SARS-CoV-2 virology provides a notable number of possible immunological procedures and drug targets. However, gaps remain in our understanding of the pathogenesis of COVID-19. In this review, we describe the latest information in the context of immunological approaches and emerging current antiviral strategies for COVID-19 treatment. |
| metadata.artigo.dc.identifier.uri: | https://www.sciencedirect.com/science/article/pii/S1567576920323092 http://repositorio.ufla.br/jspui/handle/1/42993 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.